For pharma, Trump versus Harris is a showdown between two industry foes

Contributing sentiments towards policy:

71% : Harris has received $518,571 from the industry, and Trump has received $204,748.
48% : She has promised to extend both the annual drug spending cap and the insulin price cap to all Americans with insurance, not just those on Medicare, if elected president.
47% : He sought during his administration to tie drug prices in Medicare to lower international prices, a proposal that the PricewaterhouseCoopers health research institute estimated would cost five drugmakers as much as $500 million a year.
46% : For more than a decade, manufacturers successfully fended off proposals to let Medicare negotiate lower drug prices before losing the battle two years ago.
44% : As president, Trump would likely retain Medicare price negotiations unless the pharmaceutical industry can come up with something more compelling to offer, people close to him say.
44% : Although Republicans as a party remain more friendly to the pharmaceutical industry, Trump has been willing to take action to combat high drug costs.
43% : Trump issued a rule setting up a path to import drugs from Canada and other countries.
37% : Harris cast the tie-breaking Senate vote in 2022 for legislation that allows Medicare to negotiate drug prices for its more than 60 million beneficiaries.
33% : On his campaign website, Trump posted a video in which he questioned whether childhood health problems are the result of "overprescription" of medications.
32% : The drug industry could benefit, though, if Trump remains unable to advance such proposals.
28% : "Trump hasn't said much about drug prices in his 2024 campaign, but allies and former advisers say he remains committed to knocking down prescription prices if reelected.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.